Emmaus Life Sciences Stock Alpha and Beta Analysis
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Emmaus Life Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Emmaus Life over a specified time horizon. Remember, high Emmaus Life's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Emmaus Life's market risk premium analysis include:
Beta 0.0 | Alpha 0.0 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Emmaus |
Emmaus Life Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Emmaus Life market risk premium is the additional return an investor will receive from holding Emmaus Life long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Emmaus Life. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Emmaus Life's performance over market.| α | 0.00 | β | 0.00 |
Emmaus Life Upcoming Company Events
As portrayed in its financial statements, the presentation of Emmaus Life's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Emmaus Life's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Emmaus Life's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Emmaus Life. Please utilize our Beneish M Score to check the likelihood of Emmaus Life's management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Emmaus Life
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Other Information on Investing in Emmaus OTC Stock
Emmaus Life financial ratios help investors to determine whether Emmaus OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Emmaus with respect to the benefits of owning Emmaus Life security.